imiquimod cream, 3.75%

DRUG2 trials

Sponsors

Actavis Mid-Atlantic LLC, Teva Pharmaceuticals USA

Conditions

Actinic KeratosesActinic Keratosis

Phase 3

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

CompletedNCT01686152

Teva Pharmaceuticals USAActinic Keratosis

Start: 2012-09-30End: 2013-08-31Updated: 2020-11-24

Unknown Phase

A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

CompletedNCT01502020

Actavis Mid-Atlantic LLCActinic Keratoses

Start: 2011-02-28End: 2011-11-30Updated: 2011-12-30